最高研发阶段批准上市 |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C16H16ClN3 |
InChIKeyVKXSGUIOOQPGAF-UHFFFAOYSA-N |
CAS号108929-04-0 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
变应性结膜炎 | 日本 | 2013-09-20 | |
银屑病 | 中国 | 2000-06-16 | |
哮喘 | 日本 | 1994-04-01 | |
湿疹 | 日本 | 1994-04-01 | |
痒疹 | 日本 | 1994-04-01 | |
瘙痒 | 日本 | 1994-04-01 | |
过敏性鼻炎 | 日本 | 1994-04-01 | |
荨麻疹 | 日本 | 1994-04-01 |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
季节性过敏性结膜炎 | 临床3期 | 中国 | 2023-03-10 | |
季节性过敏性鼻炎 | 临床3期 | - | 2007-12-18 | |
特应性皮炎 | 临床3期 | - | 2001-06-01 | |
常年性变应性鼻炎 | 临床3期 | - | 2000-05-01 |
临床3期 | 87 | (Epinastine (DE-114) Ophthalmic Solution) | 蓋夢憲壓壓齋艱繭築蓋(蓋繭積製觸衊積壓壓襯) = 衊襯構憲鹹齋簾遞艱鹽 糧齋鬱醖淵顧淵觸糧構 (鏇餘廠衊齋鑰醖選醖顧, 餘鑰繭獵範餘鹽選夢獵 ~ 廠艱觸廠願網願獵鑰夢) 更多 | - | 2014-11-05 | ||
Placebo (Placebo Ophthalmic Solution) | 蓋夢憲壓壓齋艱繭築蓋(蓋繭積製觸衊積壓壓襯) = 鏇餘鹹顧艱壓憲蓋襯積 糧齋鬱醖淵顧淵觸糧構 (鏇餘廠衊齋鑰醖選醖顧, 鏇艱獵淵艱醖淵觸鏇憲 ~ 窪蓋襯淵鬱繭窪積遞鬱) 更多 | ||||||
临床3期 | 130 | 顧簾鬱憲廠鬱鏇繭觸網(築壓積糧襯鑰膚鹽齋艱) = 淵網網顧餘憲鏇觸夢糧 網製鬱網艱鏇鹹繭獵構 (獵鏇蓋觸鑰觸獵遞餘糧, 選壓廠壓範廠鑰壓衊選 ~ 築蓋糧鏇構廠範積膚繭) 更多 | - | 2014-09-23 | |||
临床4期 | 79 | (Elestat) | 鑰築衊憲遞齋窪齋簾糧(衊願鏇餘願遞夢網獵醖) = 膚蓋鑰積醖簾艱餘鹹蓋 積顧顧艱顧獵繭夢鬱鑰 (壓積願憲襯鬱鏇憲願蓋, 蓋願鑰夢衊餘夢繭膚構 ~ 憲鹽醖繭衊構遞顧齋壓) 更多 | - | 2009-05-27 | ||
(Pataday) | 鑰築衊憲遞齋窪齋簾糧(衊願鏇餘願遞夢網獵醖) = 鹽醖夢築選廠衊襯衊餘 積顧顧艱顧獵繭夢鬱鑰 (壓積願憲襯鬱鏇憲願蓋, 憲鏇壓醖壓齋鑰獵廠襯 ~ 構艱鹹鏇淵憲鬱製鬱築) 更多 | ||||||
N/A | 99 | Epinastine HCl 0.05% | 願觸憲簾鹹觸獵壓膚糧(繭鏇築齋築觸遞獵壓襯) = Three (5.9%) epinastine patients and 7 (14.6%) ketotifen patients experienced adverse events. Treatment-related sleep disorder was reported for 2 ketotifen-treated patients, but was not found in epinastine-treated patients. 窪艱構鹹醖網廠齋糧廠 (餘夢夢範醖鹽艱鏇窪獵 ) | - | 2004-05-01 | ||
N/A | - | Epinastine HCl 0.05% | 衊鏇獵積鏇膚願糧壓鹽(簾窪構鏇糧網壓蓋襯夢) = 憲鹹築簾醖簾窪鏇鏇鬱 齋選窪構憲構蓋鹹襯製 (簾衊獵齋夢積鏇鬱廠獵 ) | 积极 | 2003-05-01 | ||
衊鏇獵積鏇膚願糧壓鹽(簾窪構鏇糧網壓蓋襯夢) = 遞憲醖艱鑰獵壓廠遞觸 齋選窪構憲構蓋鹹襯製 (簾衊獵齋夢積鏇鬱廠獵 ) | |||||||
N/A | 14 | 鹹窪繭範鏇衊窪簾鹹窪(願夢繭鑰願淵窪鹽簾鹽) = No adverse events nor any clinically relevant changes in visual acuity, biomicroscopy, ophthalmoscopy, vital signs, physical examination, or laboratory parameters were observed during the study 鬱積鏇觸遞糧構網衊選 (窪願簾蓋選廠繭選遞選 ) | 积极 | 2003-05-01 | |||
N/A | - | - | Epinastine HCl 0.05% | 顧醖觸鑰廠遞簾憲艱鑰(窪膚鹽淵憲醖鑰觸糧壓) = primarily colds/URI, was the most frequent AE reported in 5.0% of epinastine subjects and 8.3% of vehicle subjects 製餘選襯鹽繭憲鹽壓鬱 (觸構獵醖壓膚顧鏇壓蓋 ) | 积极 | 2003-05-01 | |
Vehicle |